Pākuʻi Daclizumab

Anter

• Ma mua o ka hoʻohana ʻana i ka pahu kui daclizumab,
• Hoʻokumu paha ʻo Daclizumab injection i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo Aʻo IMPORTANT, a kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

ʻAʻohe o Daclizumab injection i loaʻa hou. Inā ʻoe e hoʻohana ana iā daclizumab i kēia manawa, pono ʻoe e kāhea i kāu kauka e kūkākūkā i ka hoʻololi ʻana i kahi lāʻau ʻē aʻe.

Hiki i ka Daclizumab ke kumu i nā hōʻino ate a weliweli paha i ke ola. Hiki ke hoʻonui ʻia ka makaʻu o ka hōʻino ʻana o ke akepaʻa i ka poʻe e lawe ana i nā lāʻau ʻē aʻe i ʻike ʻia e hōʻino ai i ke ake, a i ka poʻe i loaʻa i ka maʻi ate. E haʻi i kāu kauka inā loaʻa a loaʻa paha iā ʻoe kahi pilikia ate a i ʻole hepatitis. E haʻi paha kāu kauka iā ʻoe mai hoʻohana i ka injection daclizumab. E haʻi i kāu kauka a me ka mea kauka lāʻau e pili ana i nā lāʻau a pau āu e lawe nei i hiki iā lākou ke nānā inā paha e hoʻonui paha kekahi o kāu mau lāʻau i ka makaʻala e hoʻomohala ʻoe i ka hōʻino o ke ake i kāu mālama ʻana me daclizumab E kiaʻi kāu kauka iā ʻoe no nā hōʻailona o nā pilikia o ke ake a i nā mahina 6 ma hope o kou mālama ʻana me daclizumab. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke aku i kāu kauka: nausea, luaʻi, luhi nui loa, kahe ʻana o ke kōkō a ʻeha paha, ka nele o ka ikaika, nalo ʻole o ka makemake, ʻeha ma ka ʻaoʻao ʻākau i luna o ka ʻōpū, melemele o ka ʻili a me nā maka. , mimi ʻeleʻele, a i ʻole nā ​​hōʻailona like flu.

Hiki i ka Daclizumab ke kumu i nā maʻi ʻōnaehana koʻikoʻi (nā hanana i kū i ka wā e hoʻouka ka ʻōnaehana immune i nā pūnaewele olakino i ke kino). E haʻi i kāu kauka inā loaʻa a loaʻa paha iā ʻoe nā pilikia ʻili, me eczema a i ʻole psoriasis. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka: ʻulaʻula, ʻili, a ʻili paha o ka ʻili; ʻōhū hāhā i ka ʻāʻī, nā ʻāpana lima, a i ʻole ke auwaha; pāhoehoe; nā noho koko; ʻeha ka ʻōpū; a i ʻole kahi hōʻailona hou ʻole i wehewehe ʻia e pili ana i nā ʻāpana o kou kino.

Ma muli o nā pilikia me kēia lāʻau, loaʻa wale ka injection daclizumab ma o kahi papahana hoʻokaʻawale palena kūikawā wale nō. Ua hoʻonohonoho ʻia kahi papahana e ka mea hana o daclizumab e hōʻoia i ka hoʻohana ʻole o ka poʻe i ka injection daclizumab me ka ʻole o ka nānā pono ʻana i kapa ʻia ʻo Zinbryta Risk Evaluation and Mitigation Strategies (REMS) Program. Pono e kau inoa kāu kauka a me kāu kauka lāʻau me ka papahana Zinbryta REMS. E noi i kāu kauka no ka ʻike hou aku e pili ana i kēia papahana a pehea ʻoe e loaʻa ai i kāu lāʻau.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha kāu kauka i kekahi mau hoʻokolohua ma mua, i ka wā, a no 6 mau mahina ma hope o kāu hopena hope loa e nānā i ka pane o kou kino i ka hoʻopiʻi daclizumab.

E hāʻawi aku kāu kauka a kauka paha iā ʻoe i ka pepa ʻikepili a ka mea hana (Kauka Lapaʻau) ke hoʻomaka ʻoe i ka mālama ʻana me ka injection daclizumab a i kēlā me kēia manawa e hoʻopiha hou i kāu kauka. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) e kiʻi i ke alakaʻi Medication.

E kamaʻilio me kāu kauka e pili ana i ka makaʻu (s) o ka loaʻa ʻana o ka injection daclizumab.

Hoʻohana ʻia ʻo Daclizumab i mea e pale ai i nā ʻāpana o nā hōʻailona a hoʻolohi i ka hōʻino ʻana o ke kīnā ʻole i ka poʻe i loaʻa i nā ʻano remapsing remapsing (papa o ka maʻi kahi e piʻi ai nā ʻōuli mai kēlā me kēia manawa) o nā sclerosis he nui (MS; kahi maʻi kahi e holo ʻole ai nā ʻalalā. kūpono a ʻike paha ka poʻe i ka nāwaliwali, numbness, nalo ʻana o ka coordination o nā mākala, a me nā pilikia me ka hihi, kamaʻilio, a me ka mālama ʻana i ka maʻi ʻaʻa. Hoʻohana maʻamau ʻia ʻo Daclizumab e ka poʻe i kōkua ʻole ʻia e ʻelua mau lāʻau ʻē aʻe no MS. Aia ʻo Daclizumab i kahi papa o nā lāʻau i kapa ʻia ʻo nā immunomodulator. Manaʻo ʻia e hana ma ka hōʻemi ʻana i ka mumū a me ka hōʻemi ʻana i ka hana o nā hunaola ʻino e hiki ai ke hōʻino i nā nerve.

Hele mai ʻo Daclizumab ma ke ʻano he hopena (wai) i kahi syringe prefilled e hoʻokomo i subcutaneously (ma lalo o ka ʻili). Hoʻokomo pinepine ʻia ia i hoʻokahi manawa i ka mahina. E hāhai pono i nā ʻōkuhi i kāu lepili kuhikuhi, a nīnau i kāu kauka a kauka paha e wehewehe i kahi ʻāpana āu i maopopo ʻole ai. E hoʻohana pono iā daclizumab e like me ke kuhikuhi. Mai hoʻohana i ka ʻoi aku a i ʻole ka liʻiliʻi o ia mea a hoʻohana pinepine paha iā ia ma mua o ka mea i kauoha ʻia e kāu kauka.

E loaʻa iā ʻoe kāu kau mua o daclizumab ma ke keʻena o kāu kauka. Ma hope o kēlā, hiki iā ʻoe ke hoʻopili iā daclizumab iā ʻoe iho a i ʻole he hoaaloha a ʻohana paha e hana i nā injection. Ma mua o kou hoʻohana ʻana iā daclizumab iā ʻoe iho i ka manawa mua, e heluhelu i nā ʻōkuhi i kākau ʻia me ia. E noi i kāu kauka a kauka paha e hōʻike iā ʻoe a i ʻole i ke kanaka e hoʻopili ana i ka lāʻau pehea e ʻoki ai iā ia.

Hiki iā ʻoe ke hoʻopili iā daclizumab i ka hope o kou mau lima kiʻekiʻe, kahi o ka ʻōpū, a i ʻole kou mau ʻūhā. Mai hoʻokomo i kāu lāʻau i loko o ka ʻili i hoʻonāukiuki ʻia, ʻōpala, ʻulaʻula, maʻi, ʻulaʻula, a me ka peʻa.

Mai hoʻohana hou a mahele paha i nā nila a i ʻole nā ​​syringes prefilled o ka lāʻau. Kiola i nā syringes i hoʻohana ʻia i loko o ka pahu kūpaʻa. E kamaʻilio me kāu kauka a kauka paha e pili ana i ka hoʻolei ʻana i ka ipu kūpaʻa.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka hoʻohana ʻana i ka pahu kui daclizumab,

• e haʻi i kāu kauka a me ka kauka inā he maʻi ʻoe i ka daclizumab, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka injection daclizumab. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa ʻoe i ka maʻi maʻi ʻaʻai a i ʻole inā loaʻa ʻoe i kahi maʻi. Eia kekahi, e haʻi i kāu kauka inā ua loaʻa ʻoe i ke kaumaha a i ʻole inā ua noʻonoʻo paha e pili ana a i ʻole i hoʻāʻo i ka pepehi kanaka.
• e haʻi i kāu kauka inā hāpai ʻoe, hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka hoʻohana ʻana iā daclizumab, e kāhea i kāu kauka.
• pono ʻoe e ʻike e lilo ʻoe i kaumaha a i ʻole suicidal (e noʻonoʻo e pili ana i ka hōʻeha a pepehi paha iā ʻoe iho a i ʻole ke hoʻolālā ʻana a hoʻāʻo ʻana e hana pēlā) ʻoiai ʻoe e hoʻohana nei i ka injection daclizumab. ʻO ʻoe, kou ʻohana, a i ʻole kāu mea mālama e kāhea koke aku i kāu kauka inā ʻike ʻoe i kekahi o nā hōʻailona aʻe: ke kaumaha hou a i ʻole ke kaumaha paha, ke kamaʻilio ʻana a i ʻole ka noʻonoʻo ʻana e makemake ana e hōʻeha iā ʻoe iho a i ʻole hoʻopau i kou ola, a i ʻole nā ​​hoʻololi ʻē aʻe i ke ʻano a me ke ʻano . E ʻike pono i kou ʻohana a mea mālama paha e ʻike i nā hōʻailona e koʻikoʻi paha i hiki iā lākou ke kāhea i ke kauka inā ʻaʻole hiki iā ʻoe ke ʻimi iā ʻoe lāʻau ponoʻī.
• ʻaʻohe o nā lāʻau lapaʻau i ka wā o kāu mālama ʻana me daclizumab a i ʻole 4 mau mahina ma hope o kāu hopena hope loa me ke kamaʻilio ʻole ʻana me kāu kauka.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā ʻoe e nalo i kahi mahele o ke kuʻi daclizumab, e hoʻokomo i kāu lāʻau i hala i kou wā e hoʻomanaʻo ai. Eia nō naʻe, inā ʻoi aku ia ma mua o 2 mau pule ma hope o kāu nalo ʻana, haʻalele i ka lāʻau i hala a hoʻomau i kāu papa hana maʻamau. Mai hoʻokomo i kahi lāʻau pālua e pani no kahi mahele hala. Kāhea i kāu kauka inā haʻalele ʻoe i kahi lāʻau a he nīnau kāu e pili ana i ka mea e hana ai.

Hoʻokumu paha ʻo Daclizumab injection i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• huehue
• ʻeha ka waha

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo Aʻo IMPORTANT, a kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

• hūwī
• hives
• ʻūlili
• pilikia i ka hanu ʻana a i ʻole ke ale ʻana
• pehu o nā maka, maka, waha, alelo, a puʻu paha
• kaumaha hou a i ʻole ke kaumaha paha
• nā hoʻololi i ke ʻano a me ke ʻano
• ke noʻonoʻo nei e pili ana i ka hōʻino a pepehi paha iā ʻoe iho a i ʻole ke hoʻolālā ʻana a hoʻāʻo ʻana paha e hana pēlā
• ihu ihu, ʻūhū, ʻāʻī ʻeha, kuni, a me nā anu ʻē aʻe o ka maʻi
• pilikia urino
• ʻeha ke ʻimi
• ka hopu ʻana

Hoʻokumu paha ʻo Daclizumab i nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i kēia lāʻau i loko o ka pahu i komo ai, pani paʻa ʻia, a ʻaʻole hiki i nā kamaliʻi. E mālama iā daclizumab i loko o ka pahu hau akā mai paʻa. Inā kūʻā wale ʻoe i ka lāʻau, pono ʻoe e hoʻolei i ke ʻele. Mālama ʻia ʻo Daclizumab i ka mahana wela a hiki i 30 mau lā akā e pale ʻia ia mai ka mālamalama. ʻAʻole pono e hoʻihoʻi ʻia ʻo Daclizumab i loko o ka pahu hau ma hope o ka mālama ʻia ʻana i ke ana wela o ka lumi.

Pono e hoʻolei ʻia nā lāʻau i koi ʻole ʻia i nā ala kūikawā e hōʻoia i ka hiki ʻole i nā holoholona, ​​nā keiki, a me nā poʻe ʻē aʻe ke hoʻopau iā lākou. Eia nō naʻe, ʻaʻole pono ʻoe e kaomi i kēia lāʻau i ka lua. Akā, ʻo ke ala ʻoi loa e hoʻolilo i kāu lāʻau i loko o kahi papahana hoʻihoʻi lāʻau. E kamaʻilio me kāu kauka lāʻau a kāhea paha i kāu ʻōpala a me nā hana hoʻopōʻaiapuni kūloko e aʻo e pili ana i nā papahana hoʻihoʻi i kou kaiāulu. E ʻike i ka pūnaewele palekana o kā FDA's Disposal of Medicines (http://goo.gl/c4Rm4p) no ka ʻike hou aku inā ʻaʻohe ou komo i kahi papahana hoʻihoʻi.

He mea nui e mālama i nā lāʻau āpau mai ka maka a hiki i nā keiki e like me nā ipu (e like me nā minder pill i kēlā me kēia pule a me nā mea no nā kulu maka, nā kalima, nā pākuʻi, a me nā inhalers) ʻaʻole pale keiki a hiki i nā keiki ʻōpio ke wehe maʻalahi iā lākou. No ka pale ʻana i nā keiki ʻōpio mai ka lāʻau make, laka mau i nā pāpale palekana a kau koke i ka lāʻau i kahi palekana - kahi i luna a mamao a mai ko lākou alo a hiki. http://www.upandaway.org

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

Ma mua o ka loaʻa ʻana o kahi hoʻokolohua hoʻokolohua, e haʻi i kāu kauka a me nā limahana o ke keʻena hoʻokolohua āu e hoʻohana nei i ka injection daclizumab.

Mai ʻae i kahi mea ʻē aʻe e lawe i kāu lāʻau. E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka hoʻopiha hou ʻana i kāu kuhikuhi.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• Zinbryta^®
• Zenapax^®¶

^¶ ʻAʻole kēia huahana māka i ka mākeke hou. Hiki ke loaʻa nā koho ʻē aʻe.